Early hemoglobin response to epoetin alfa is associated with significantly better clinical outcomes in breast cancer patients

被引：0

|

作者：

Lefevbre, P

Rosberg, J

Duh, MS

McKenzie, RS

Fastenau, J

Piech, CT

机构：

[1] Anal Grp Inc, Boston, MA USA

[2] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：S231 / S231

页数：1

相关论文

共 50 条

[1] TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients
Gaweda, Adam E.
Bhat, Premila
Maglinte, Gregory A.
Chang, Chun-Lan
Hill, Jerrold
Park, Grace S.
Ashfaq, Akhtar
Gitlin, Matthew
HEMODIALYSIS INTERNATIONAL, 2014, 18 (01) : 38 - 46
[2] Clinical outcomes associated with conversion from epoetin alfa to darbepoetin alfa in hospitalized hemodialysis patients
Sarac, Erdal
Chikyarappa, Anand
Sabol, Brian
Gemmel, David
Globe, Denise
Barlev, Arie
Audhya, Paul
AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (06) : 571 - 578
[3] Early intervention with epoetin alfa is associated with reduced drug utilization in anemic breast cancer patients.
Chang, J.
Chan, D.
Camacho, F.
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S282 - S282
[4] Strategies for optimizing hemoglobin response in cancer patients: focus on new epoetin alfa dosing regimens
Sabbatini, P
EJC SUPPLEMENTS, 2004, 2 (02): : 36 - 40
[5] Greater area under the hemoglobin change curve is associated with improved outcomes in breast cancer patients receiving epoetin alfa for chemotherapy-related anemia.
Lefebvre, P
Duh, MS
McKenzie, RS
Piech, CT
BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S214 - S215
[6] Benefits of early hemoglobin response to epoetin alfa in elderly patients with chemotherapy-related anemia.
Rosberg, J
Cremieux, PY
McKenzie, SR
Fastenau, JM
Piech, CT
BLOOD, 2004, 104 (11) : 609A - 609A
[7] Early intervention with Epoetin alfa: Effect on hemoglobin levels in lung cancer patients - Dutch survey results
Biesma, B
van der Werf, R
ten Velde, G
Melissant, C
LUNG CANCER, 2005, 49 : S55 - S55
[8] Early treatment of mild anemia with once-weekly epoetin alfa significantly improves hemoglobin and quality of life in early-stage breast cancer patients during conventional adjuvant chemotherapy.
Hudis, CA
Williams, D
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S154 - S154
[9] Epoetin alfa treatment of anaemic breast cancer patients: Haematological and quality of life (QOL) outcomes
Demetri, G
ANNALS OF ONCOLOGY, 1998, 9 : 140 - 141
[10] Comparison of anemia outcomes associated with early response to epoetin alfa (EPO) withQW and TIW dosing.
McKenzie, RS
Lefebvre, P
Rosberg, J
Duh, MS
Fastenau, J
Piech, CT
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 553S - 553S

← 1 2 3 4 5 →